NTC news: Post-cataract surgery

23 Jul 2019

Last June, in Milan, NTC held a very important Investigators’ Meeting of two pivotal registration studies for a novel drug indicated in post cataract surgery: over 50 centers were involved in such large clinical effort and attended the event.

NTC is fostering antibiotic culture in an environment largely impacted by antibiotic resistance, promoting innovation and creating new therapeutic solutions available on worldwide scale.

NTC‘s products are supported by significant evidence based medicine leveraging large randomized clinical trials.

NTC news: Post-cataract surgery